Daniel Kerage is from Kenya and was awarded the Norman E. Borlaug Leadership Enhancement in Agriculture Program (LEAP) fellowship in Summer 2006. He was enrolled in the Master's program at Kenyatta University in the Department of Biochemistry & Biotechnology. The project was aimed at evaluating the potential of the bacterium Listeria monocytogenes as a vaccine carrier against a highly fatal lympho-proliferative cattle disease called the East Coast Fever (ECF), which is endemic in Eastern, Central, and Southern Africa. Specifically, he intended to evaluate the potential of live attenuated recombinant Listeria monocytogenes expressing Cytotoxic T Lymphocytes (CTLs) Theileria parva vaccine candidate antigens to induce CTL responses in cattle and determine whether these immune responses can protect against a lethal parasite challenge.
Dr. John Harty at University of Iowa, Dr. Simon Graham at Veterinary Laboratories Agency, VLA, UK, Dr. Duncan Mwangi at ILRI, and Dr. Eucharia Kenya at Kenyatta University all had a hand in mentoring Dr. Kerage during his fellowship.
In 2013, Dr. Kerage won the prestigious Pfizer President's Presenter Award for his work the listeria monocotygene vaccine while at ILRI. He completed his PhD in the Department of Medical Microbiology and Immunology at the University of Alberta, Canada in 2016, researching the direct and indirect effects of cytomegalovirus infection on vascular function during pregnancy.